Is D-Wave Quantum Stock a Buy?

D‑Wave Quantum (QBTS), which went public via SPAC in August 2022 and whose shares have swung from $10 to under $1 in 2023 and back to about $12, markets quantum‑annealing systems and cloud services (Leap) and counts more than 100 pilot customers including Deloitte, Mastercard and Volkswagen but currently derives little recurring revenue from those engagements; revenue was $7.2m in 2022 and flat at $8.8m in 2023–24, is forecast to jump to $25.4m in 2025 on sales of its new Advantage2 systems and to $75m by 2027, yet adjusted EBITDA and GAAP losses are widening (adjusted EBITDA expected −$70.6m and net loss −$338.9m in 2025) as it scales. While market forecasts point to strong long‑term growth in quantum computing, D‑Wave’s enterprise value of roughly $9.9bn (about 132x projected 2027 sales versus 55x for peer IonQ) leaves limited near‑term upside absent substantial revenue conversion, making the stock a high‑risk, valuation‑constrained play to monitor rather than an immediate buy.

Analysis

D-Wave Quantum (QBTS) is a quantum-annealing hardware and cloud-services provider that went public via SPAC on Aug. 8, 2022; its share price has swung from a $10 open to sub-$1 in 2023 and now about $12, and it serves more than 100 customers including Deloitte, Mastercard, Volkswagen, Lockheed Martin and Accenture primarily through low-revenue pilots on its Leap platform. The company’s revenue was $7.2 million in 2022, $8.8 million in 2023 and flat at $8.8 million in 2024, with a projected jump to $25.4 million in 2025 driven by Advantage2 system sales, while adjusted EBITDA and GAAP net losses are expected to widen to negative $70.6 million and negative $338.9 million in 2025 respectively. Analysts forecast revenue reaching $75 million by 2027 with improving but still negative adjusted EBITDA (-$64 million) and a narrower net loss (-$115 million), reflecting reliance on converting pilot engagements into higher-value partnerships and infrequent $20–$40 million system sales.

The company differentiates via superconducting flux qubits and remote delivery of quantum annealing torsks, and claims Advantage2 can address 3D lattice problems up to 25,000x faster than first-generation systems; market research cited projects market CAGRs of ~15.7% for annealing and ~20.5% for broader quantum through the late 2020s. Despite the technology roadmap and customer logos, D-Wave’s enterprise value of roughly $9.9 billion implies about 132x projected 2027 sales—materially higher than peer IonQ at 55x on its 2027 estimate—creating a valuation-sensitive upside that could compress if revenue conversion disappoints. Given the anticipated step-up in R&D and sales spending and the need to prove recurring commercial revenue, the stock appears to be a high-risk, thesis-driven play to monitor for evidence of durable commercial adoption rather than a near-term buy.

Key Decisions for Investors

• Delay material new purchases until the company demonstrates sustained quarter-over-quarter revenue growth and clear pilot-to-paid conversion metrics from the Leap platform
• Treat any position as speculative and size exposure conservatively given a stated enterprise value of ~$9.9bn and 132x projected 2027 sales relative to peers
• Use the 2025 Advantage2 sales cadence and actual 2025 revenue/EBITDA results as primary catalysts; consider initiating positions only after confirmed Advantage2 orders or a revenue beat
• Monitor cash burn, adjusted EBITDA trajectory and signs of balance-sheet dilution risk from additional financing, and hedge or reduce exposure if net losses accelerate beyond current forecasts